US Stock MarketDetailed Quotes
ALLR Allarity Therapeutics
- 1.4600
- +0.0300+2.10%
Close Apr 26 16:00 ET
2.84MMarket Cap-7P/E (TTM)
1.7000High1.4300Low188.29KVolume1.7000Open1.4300Pre Close285.78KTurnover9.68%Turnover RatioLossP/E (Static)1.95MShares366.400052wk High-0.63P/B2.84MFloat Cap1.270052wk Low--Dividend TTM1.95MShs Float509600.0000Historical High--Div YieldTTM18.88%Amplitude1.2700Historical Low1.5170Avg Price1Lot Size
Allarity Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 24.21%-12.75M | 31.64%-1.67M | -21.96%-5.38M | 40.68%-2.5M | 44.38%-3.2M | -12.97%-16.82M | 43.37%-2.45M | -18.05%-4.41M | 1.36%-4.21M | -124.19%-5.76M |
| Net income from continuing operations | 25.89%-11.9M | 39.32%-1.72M | 11.71%-4.45M | 53.36%-2.38M | -8.83%-3.35M | 39.74%-16.06M | 83.12%-2.84M | -273.11%-5.04M | 5.43%-5.1M | 0.16%-3.08M |
| Operating gains losses | 68.20%-5.83M | -4.03%-3.51M | 97.14%-10K | -243.45%-1.91M | 97.18%-396K | -676.79%-18.34M | -1,830.29%-3.38M | 86.37%-350K | -452.53%-557K | -6,402.69%-14.06M |
| Depreciation and amortization | -38.33%37K | 350.00%9K | -18.18%9K | -62.50%9K | -56.52%10K | -43.40%60K | -87.50%2K | -70.27%11K | 900.00%24K | -58.93%23K |
| Deferred tax | 106.02%97K | 135.93%97K | --0 | --0 | --0 | -8,160.00%-1.61M | -114.29%-270K | -170.83%-119K | 107.27%4K | -3,818.18%-1.23M |
| Other non cash items | 1,040.58%1.57M | 129.36%234K | 820.48%764K | -40.80%489K | 234.62%87K | -93.30%138K | -176.34%-797K | 538.46%83K | 19.71%826K | -91.67%26K |
| Change In working capital | 1,121.95%3.35M | 273.58%3.48M | -403.68%-1.82M | 70.32%1.12M | 122.71%571K | -105.89%-328K | -85.84%931K | 197.71%598K | 806.45%657K | -735.22%-2.51M |
| -Change in receivables | ---26K | -4.96%748K | 93.81%-12K | -435.51%-739K | 94.95%-23K | --0 | --787K | -68.70%-194K | -94.37%-138K | -12.90%-455K |
| -Change in prepaid assets | 69.26%-190K | -231.90%-385K | -145.71%-176K | 10.88%377K | 99.51%-6K | -575.38%-618K | -243.21%-116K | 459.81%385K | 33,900.00%340K | -891.61%-1.23M |
| -Change in payables and accrued expense | 51.84%2.23M | 31.44%2.3M | -647.37%-2.18M | 148.00%1.49M | 149.02%627K | -75.13%1.47M | -71.68%1.75M | 170.25%399K | 171.49%600K | -1,782.89%-1.28M |
| -Change in other current assets | 225.35%1.35M | 155.97%820K | 1,584.85%556K | 93.91%-7K | -104.04%-19K | -226.36%-1.08M | -528.76%-1.47M | -84.58%33K | 46.76%-115K | 594.74%470K |
| -Change in other current liabilities | 91.92%-8K | --0 | --0 | --0 | 65.22%-8K | 20.16%-99K | 19.23%-21K | 30.56%-25K | -7.14%-30K | 32.35%-23K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 24.21%-12.75M | 31.64%-1.67M | -21.96%-5.38M | 40.68%-2.5M | 44.38%-3.2M | -12.97%-16.82M | 43.37%-2.45M | -18.05%-4.41M | 1.36%-4.21M | -124.19%-5.76M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 0 | -21.29%791K | -460.00%-18K | 0 | 0 | 809K |
| Net PPE purchase and sale | --0 | ---- | ---- | ---- | ---- | ---18K | ---- | ---- | ---- | ---- |
| Net intangibles purchase and sale | --0 | --0 | --0 | --0 | --0 | -19.50%809K | --0 | --0 | --0 | --809K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | --0 | --0 | -21.29%791K | -460.00%-18K | --0 | --0 | --809K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 938.67%11M | -47.80%522K | 6.45M | 223.97%2.87M | 1.16M | -103.88%-1.31M | -94.58%1M | 0 | -121.58%-2.31M | 0 |
| Net issuance payments of debt | -364.90%-2.65M | -100.10%-1K | ---350K | ---- | ---- | 3.20%1M | 732.91%1M | --0 | ---- | ---- |
| Net common stock issuance | --16.9M | --0 | --10.08M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net preferred stock issuance | -263.60%-5.49M | --0 | ---5M | -9.33%-1.65M | --1.16M | ---1.51M | --0 | --0 | ---1.51M | --0 |
| Proceeds from stock option exercised by employees | --2.24M | --523K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | 60.80%-800K | --0 | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 938.67%11M | -47.80%522K | --6.45M | 223.97%2.87M | --1.16M | -103.88%-1.31M | -94.58%1M | --0 | -121.58%-2.31M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -89.62%2.03M | -64.55%1.4M | -94.53%420K | -97.97%295K | -89.62%2.03M | 6,462.08%19.56M | -29.33%3.95M | 16.35%7.68M | 13,751.43%14.54M | 6,462.08%19.56M |
| Current changes in cash | 89.91%-1.75M | 21.45%-1.15M | 124.36%1.07M | 105.66%369K | 58.69%-2.04M | -186.96%-17.34M | -110.37%-1.46M | -1,036.08%-4.41M | -201.16%-6.52M | -1,943.80%-4.95M |
| Effect of exchange rate changes | 40.21%-113K | 81.68%-83K | -114.03%-95K | 29.89%-244K | 575.38%309K | 72.21%-189K | -198.03%-453K | 208.15%677K | -810.20%-348K | -232.65%-65K |
| End cash Position | -91.82%166K | -91.82%166K | -64.55%1.4M | -94.53%420K | -97.97%295K | -89.62%2.03M | -89.62%2.03M | -29.33%3.95M | 16.35%7.68M | 13,751.43%14.54M |
| Free cash flow | 24.29%-12.75M | 32.14%-1.67M | -21.96%-5.38M | 40.68%-2.5M | 44.38%-3.2M | -13.09%-16.84M | 42.95%-2.46M | -18.05%-4.41M | 1.36%-4.21M | -124.19%-5.76M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg